Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hupe

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Urologia Internationalis|September 13, 2021
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational SurveyJulian P Struck, Martin J P Hennig, Marie C Hupe, et al.
The Journal of Investigative Dermatology|April 16, 2014
Basis for enhanced barrier function of pigmented skinMao-Qiang Man, Tzu-Kai Lin, Juan L Santiago, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of β-Catenin SignalingLasse D Jensen, Belma Hot, Daniel Ramsköld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2020
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder CancerVinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 5, 2023
ICRP workshop on the review and revision of the system of radiological protection: a focus on research priorities-feedback from the international communityWerner Rühm, Hyungjoon Yu, Christopher Clement, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 11, 2024
Support for the "Vancouver call for action to strengthen expertise in radiological protection worldwide": the position of organisations in formal relations with the International Commission on Radiological Protection (ICRP)Lorenzo Nicola Mazzoni, John Damilakis, Bernard Le Guen, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Urologia Internationalis|September 13, 2021
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational SurveyJulian P Struck, Martin J P Hennig, Marie C Hupe, et al.
The Journal of Investigative Dermatology|April 16, 2014
Basis for enhanced barrier function of pigmented skinMao-Qiang Man, Tzu-Kai Lin, Juan L Santiago, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 27, 2019
Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of β-Catenin SignalingLasse D Jensen, Belma Hot, Daniel Ramsköld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2020
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder CancerVinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|September 5, 2023
ICRP workshop on the review and revision of the system of radiological protection: a focus on research priorities-feedback from the international communityWerner Rühm, Hyungjoon Yu, Christopher Clement, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 11, 2024
Support for the "Vancouver call for action to strengthen expertise in radiological protection worldwide": the position of organisations in formal relations with the International Commission on Radiological Protection (ICRP)Lorenzo Nicola Mazzoni, John Damilakis, Bernard Le Guen, et al.
Pageof 29